|
FOR US RESIDENTS ONLY
|
Patient Support/
Adherence
Adherence
who treat Ph+ CML
Chronic Myeloid Leukemia (CML)
Patient Support/Adherence
Patient support is a key component of CML AllianceTM. In partnership with leading clinicians and patient groups, Novartis has designed two integrated websites designed specifically to help people with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
CML Alliance Patient Support Program: a unique program designed to help improve adherence to therapy and provide access to reimbursement support.
- What to expect from treatment
- How to manage Ph+ CML
- How to find support
- How to communicate effectively with your medical team
Use of this website is governed by the
Terms of Use
and
Privacy Statement
.
© 2010 Novartis Pharmaceuticals Corporation. All Rights Reserved.
|